IMPACT OF HUMAN-IMMUNODEFICIENCY-VIRUS ON TRANSMISSION AND SEVERITY OF TUBERCULOSIS

被引:26
作者
NUNN, P
KIBUGA, D
ELLIOTT, A
GATHUA, S
机构
[1] UNIV LONDON LONDON SCH HYG & TROP MED,LONDON WC1E 7HT,ENGLAND
[2] KENYATTA NATL HOSP,HOSP INFECT DIS,NAIROBI,KENYA
[3] UNIV ZAMBIA,HOSP TEACHING,LUSAKA,ZAMBIA
关键词
D O I
10.1016/0035-9203(90)90448-N
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
It is now clear that tuberculosis is one of the major diseases associated with human immunodeficiency virus (HIV) infection and the acquired immune deficiency syndrome both in developing countries and in disadvantaged groups in the northern hemisphere. In the USA, and probably several other countries, the annual incidence of tuberculosis is rising as a result of the HIV epidemic. This is probably a result of an increase in both pulmonary and, especially, extrapulmonary tuberculosis, due to reactivation of latent infections, but a secondary increase in the infection rate is also possible. The hard-won gains in tuberculosis control of the last 30 years are thus in jeopardy. This article focuses on the effect HIV is likely to have on the known risk factors for infection with Mycobacterium tuberculosis and for reactivation. Whilst HIV-associated tuberculosis may be indistinguishable from HIV-negative disease, it is likely in other cases to present diagnostic difficulties, to respond poorly to treatment with more adverse effects, and to result in high early mortality, although this may not be due directly to tuberculosis. HIV-associated tuberculosis thus represents a major challenge to physicians, especially in developing countries, but like other forms of tuberculosis it is (i) treatable and (ii) preventable. © 1990, Oxford University Press. All Rights Reserved.
引用
收藏
页码:9 / 13
页数:5
相关论文
共 34 条
  • [1] CENTRAL-NERVOUS-SYSTEM TUBERCULOSIS WITH THE ACQUIRED-IMMUNODEFICIENCY-SYNDROME AND ITS RELATED COMPLEX
    BISHBURG, E
    SUNDERAM, G
    REICHMAN, LB
    KAPILA, R
    [J]. ANNALS OF INTERNAL MEDICINE, 1986, 105 (02) : 210 - 213
  • [2] TUBERCULOSIS IN PATIENTS WITH THE ACQUIRED-IMMUNODEFICIENCY-SYNDROME - CLINICAL-FEATURES, RESPONSE TO THERAPY, AND SURVIVAL
    CHAISSON, RE
    SCHECTER, GF
    THEUER, CP
    RUTHERFORD, GW
    ECHENBERG, DF
    HOPEWELL, PC
    [J]. AMERICAN REVIEW OF RESPIRATORY DISEASE, 1987, 136 (03): : 570 - 574
  • [3] TUBERCULOSIS AND HUMAN IMMUNODEFICIENCY VIRUS-INFECTION
    CHAISSON, RE
    SLUTKIN, G
    [J]. JOURNAL OF INFECTIOUS DISEASES, 1989, 159 (01) : 96 - 100
  • [4] CHAPMAN JS, 1964, AM REV RESPIR DIS, V90, P48
  • [5] COMSTOCK GW, 1981, AM REV RESPIR DIS, P8
  • [6] MYCOBACTERIUM-TUBERCULOSIS INFECTION IN THE ACQUIRED-IMMUNODEFICIENCY-SYNDROME - A REVIEW OF 14 PATIENTS
    DUNCANSON, FP
    HEWLETT, D
    MAAYAN, S
    ESTEPAN, H
    PERLA, EN
    MCLEAN, T
    RODRIGUEZ, A
    MILLER, SN
    LENOX, T
    WORMSER, GP
    [J]. TUBERCLE, 1986, 67 (04): : 295 - 302
  • [7] HEIGHT, WEIGHT, TUBERCULOUS INFECTION, AND TUBERCULOUS DISEASE
    EDWARDS, LB
    LIVESAY, VT
    ACQUAVIVA, FA
    PALMER, CE
    [J]. ARCHIVES OF ENVIRONMENTAL HEALTH, 1971, 22 (01): : 106 - +
  • [8] ELLIOTT A, 1989, 5TH INT AIDS C MONTR, P989
  • [9] GRZYBOWSKI S, 1975, B INT UNION TUBERC, V60, P90
  • [10] CUTANEOUS MANIFESTATIONS OF HUMAN IMMUNODEFICIENCY VIRUS IN LUSAKA, ZAMBIA
    HIRA, SK
    WADHAWAN, D
    KAMANGA, J
    KAVINDELE, D
    MACUACUA, R
    PATIL, PS
    ANSARY, MA
    MACHER, AM
    PERINE, PL
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 1988, 19 (03) : 451 - 457